# Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel

> **NCT00499694** · NA · COMPLETED · sponsor: **Barbara Ann Karmanos Cancer Institute** · enrollment: 31 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** bevacizumab
- **DRUG:** satraplatin

## Key facts

- **NCT ID:** NCT00499694
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00499694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00499694, "Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00499694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*